Since 1984, much data has emerged indicating that the time of day when cancer therapies are applied can determine how much damage these agents do to normal tissues. This book summarizes this data and puts it in perspective within the fields of oncology and chronobiology. It explains the biological basis for the rhythmic host-cancer balance throughout each day and demonstrates how this balance may be favourably perturbed with predictably different degrees of success.
